ixlayer appoints Bernard Esquivel as Head of Clinical Innovation

Industry veteran to bolster company’s diagnostic lab services expansion across health plans, retail, providers, biopharma and government

ixlayer is pleased to announce Bernard Esquivel, MD, PhD, has joined the team as the Head of Clinical Innovation. Esquivel will play an instrumental role in shaping the company’s health testing strategy, including its continued expansion into the labs and diagnostics space. 

“With demand for more convenient and accessible lab testing growing among health plans, retailers and providers — so they may better support the patients they serve — forward-thinking healthcare organizations need an end-to-end platform to power better health testing,” said Pouria Sanae, ixlayer’s Chief Executive Officer and co-founder. “Dr. Esquival’s experience and clinical lens will be critical as we continue to expand our solutions and elevate industry best practices, and we’re thrilled to have him join our team.” 

A healthcare industry veteran with more than a decade of experience driving innovations in the healthcare space, Esquivel has deep knowledge and experience in various domains, from genomics and precision medicine to population health management and digital health. His career has been laser focused on making precision medicine and digital health a reality, overcoming challenges to make it clinically actionable and cost-effective.

“The healthcare industry continues to evolve and today’s focus is very much around value-based care driven by population and individual outcomes — centering the patient and their individual health data more than ever,” said Dr. Esquivel. “This is an exciting time to join the team at ixlayer and I look forward to helping foster innovation and growth in 2023 and beyond.” 

ixlayer powers diagnostics and screening programs for organizations including health plans, retail, providers, biopharma and government, that seek more accessible methods for providing preventive care to members and patients. By offering turnkey programs, through a white labeled solution to drive member engagement, ixlayer helps its partners provide high-quality health care that enables members and patients to take control of their health – through early detection, prevention, and condition management.

Please join the ixlayer team in congratulating Bernard Esquivel, MD, PhD on his new role as Head of Clinical Innovation.

 

ixLayer Platform - Population Health Management in the Covid-19 Era

ixlayer

ixlayer is the healthcare platform for user-friendly at-home and on-site health testing programs at scale. ixlayer’s solutions enable health plans, government entities, telehealth providers, retailers, health systems, pharmaceutical and biotech companies to deploy configurable programs quickly and easily.

ixlayer offers thousands of health testing options for decentralized clinical trials, closing care gaps, and direct to consumer solutions, all under today's most trusted brands.

SHARE THIS ARTICLE

You Might Also Like

Be the first to know!

Sign up to our newsletter to receive the latest industry news, and trends.